The expression of LCN2 in the PMN-MDSC in the tumor were significantly increased in stroke mice compared to that in sham mice, and it may potentially serve as an immune modulatory target for the exacerbated cancer progression in cancer-related stroke. This evidence concerns the gene LCN2 and Stroke.